Yarrow Bioscience prices 5,769,231-share follow-on at USD 26, raising USD 150 million

Reuters2026/09/11 01:11

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Yarrow Bioscience priced an underwritten public offering of 5,769,231 common shares at USD 26 per share.
Gross proceeds expected at about USD 150 million, before underwriting discounts, commissions, advisory fees, and other offering expenses.
Deal expected to close Sept. 14, 2026, subject to customary closing conditions.
Underwriters hold a 30-day option to buy up to 865,384 additional shares at the offering price.
Net proceeds earmarked for R&D spending across the pipeline, working capital, capital expenditures, and general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yarrow Bioscience Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260910667744) on September 11, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Yarrow Bioscience prices 5,769,231-share follow-on at USD 26, raising USD 150 million

You may also like

Crypto prices